<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2d1 20170631//EN" "JATS-journalpublishing1.dtd">
<ArticleSet>
  <Article>
    <Journal>
      <PublisherName>jmedicalcasereports</PublisherName>
      <JournalTitle>Frontiers in Medical Case Reports</JournalTitle>
      <PISSN>I</PISSN>
      <EISSN>S</EISSN>
      <Volume-Issue>Volume 4; Issue 4</Volume-Issue>
      <PartNumber/>
      <IssueTopic>Multidisciplinary</IssueTopic>
      <IssueLanguage>English</IssueLanguage>
      <Season>(Jul-Aug, 2023)</Season>
      <SpecialIssue>N</SpecialIssue>
      <SupplementaryIssue>N</SupplementaryIssue>
      <IssueOA>Y</IssueOA>
      <PubDate>
        <Year>-0001</Year>
        <Month>11</Month>
        <Day>30</Day>
      </PubDate>
      <ArticleType>Medical Case Reports</ArticleType>
      <ArticleTitle>The Prevalence of Hearing Loss Following Parotid Cancer Radiotherapy and Its Associated Factors: A Meta-Analysis Study</ArticleTitle>
      <SubTitle/>
      <ArticleLanguage>English</ArticleLanguage>
      <ArticleOA>Y</ArticleOA>
      <FirstPage>1</FirstPage>
      <LastPage>10</LastPage>
      <AuthorList>
        <Author>
          <FirstName>Azadeh</FirstName>
          <LastName>Amraee</LastName>
          <AuthorLanguage>English</AuthorLanguage>
          <Affiliation/>
          <CorrespondingAuthor>N</CorrespondingAuthor>
          <ORCID/>
          <FirstName>Fathollah</FirstName>
          <LastName>Mohaghegh</LastName>
          <AuthorLanguage>English</AuthorLanguage>
          <Affiliation/>
          <CorrespondingAuthor>Y</CorrespondingAuthor>
          <ORCID/>
          <FirstName>Mohamad Reza</FirstName>
          <LastName>Bayatiani</LastName>
          <AuthorLanguage>English</AuthorLanguage>
          <Affiliation/>
          <CorrespondingAuthor>Y</CorrespondingAuthor>
          <ORCID/>
          <FirstName>Masoud</FirstName>
          <LastName>Bahrami</LastName>
          <AuthorLanguage>English</AuthorLanguage>
          <Affiliation/>
          <CorrespondingAuthor>Y</CorrespondingAuthor>
          <ORCID/>
          <FirstName>Fatemeh</FirstName>
          <LastName>Seif</LastName>
          <AuthorLanguage>English</AuthorLanguage>
          <Affiliation/>
          <CorrespondingAuthor>Y</CorrespondingAuthor>
          <ORCID/>
        </Author>
      </AuthorList>
      <DOI/>
      <Abstract>Treatment of parotid cancer with radiotherapy can lead to hearing loss. The purpose of this systematic review is to evaluate the hearing loss caused by parotid cancer radiotherapy. In this article, a systematic search of Web of Science, PubMed, Google Scholar, Elsevier, Scopus, Embase and ProQues to June 2019 including patients with parotid cancer treated with radiotherapy was performed. In total, six studies were included in the meta-analysis. All these articles were follow-up studies and reported the percentage of hearing loss. The percent of hearing loss was 0.25 (95% CI: 0.07, 0.42, I2=91.6%, 6 studies). The publication bias was evaluated using Begg’s and Egger’s tests. P-values of Begg’s and Egger’s tests were 0.497 and 0.262 respectively.&#13;
&#13;
Parotid cancer radiotherapy patients may experience hearing loss. Hence it is recommended in treatment planning, that the hearing structure is drawn as an organ at risk in parotid cancer radiotherapy.</Abstract>
      <AbstractLanguage>English</AbstractLanguage>
      <Keywords>Hearing Loss,Parotid Cancer,Radiotherapy</Keywords>
      <URLs>
        <Abstract>https://jmedicalcasereports.org/ubijournal-v1copy/journals/abstract.php?article_id=14823&amp;title=The Prevalence of Hearing Loss Following Parotid Cancer Radiotherapy and Its Associated Factors: A Meta-Analysis Study</Abstract>
      </URLs>
      <References>
        <ReferencesarticleTitle>References</ReferencesarticleTitle>
        <ReferencesfirstPage>16</ReferencesfirstPage>
        <ReferenceslastPage>19</ReferenceslastPage>
        <References>Anteunis LJ, Wanders SL, Hendriks JJ, Langendijk JA, Manni JJ, de Jong JM. A prospective longitudinal study on radiation-induced hearing loss. Am J Surg 1994; 168: 408-411.&#13;
&#13;
Bance M. Hearing and aging. CMAJ 2007; 176: 925-927.&#13;
&#13;
Bass JK, Hua CH, Huang J, Onar-Thomas A, Ness KK, Jones S, White S, Bhagat SP, Chang KW, Merchant TE. Hearing loss in patients who received cranial radiation therapy for childhood cancer. J Clin Oncol 2016; 34: 1248-1255.&#13;
&#13;
Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994:1088-101.&#13;
&#13;
Bhandare N, Jackson A, Eisbruch A, Pan CC, Flickinger JC, Antonelli P, Mendenhall WM. Radiation therapy and hearing loss. Int J Radiat Oncol Biol Phys 2010; 76: S50-S57.&#13;
&#13;
Chen WC, Liao CT, Tsai HC, Yeh JY, Wang CC, Tang SG, Hong JH. Radiation-induced hearing impairment in patients treated for malignant parotid tumor. Ann Otol Rhinol Laryngol 1999; 108: 1159-1164.&#13;
&#13;
De Marzi L, Feuvret L, Bouland;eacute; T, Habrand JL, Martin F, Calugaru V, Fournier-Bidoz N, Ferrand R, Mazal A. Use of gEUD for predicting ear and pituitary gland damage following proton and photon radiation therapy. Br J Radiol 2015; 88: 20140413.&#13;
&#13;
DeVita VT, Hellman S, Rosenberg SA, editors. Cancer: Principles and Practice of Oncology: Principles and; Practice of Oncology. Wolters Kluwer/Lippincott Williams and; Wilkins; 2011.&#13;
&#13;
Egger M, Smith GD, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 629-634.&#13;
&#13;
Evans RA, Liu KC, Azhar T, Symonds RP. Assessment of permanent hearing impairment following radical megavoltage radiotherapy. J Laryngol Otol 1988; 102: 588-589.&#13;
&#13;
Halperin EC, Brady LW, Perez CA, Wazer DE. Perez and; Bradyand;#39;s principles and practice of radiation oncology. Lippincott Williams and; Wilkins; 2013 May 6.&#13;
&#13;
Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003; 327: 557-560.&#13;
&#13;
Higgins JPT, Green S. Cochrane handbook for systematic reviews of interventions. http://www. cochrane-handbook. org. 2008.&#13;
&#13;
Hua C, Bass JK, Khan R, Kun LE, Merchant TE. Hearing loss after radiotherapy for pediatric brain tumors: effect of cochlear dose. Int J Radiat Oncol Biol Phys 2008; 72: 892-899.&#13;
&#13;
Jereczek-Fossa BA, Zarowski A, Milani F, Orecchia R. Radiotherapy-induced ear toxicity. Cancer Treat Rev 2003; 29: 417-430.&#13;
&#13;
Mc Loughlin L, Gillanders SL, Smith S, Young O. The role of adjuvant radiotherapy in management of recurrent pleomorphic adenoma of the parotid gland: a systematic review. Eur Arch Otorhinolaryngol 2019; 276: 283-295.&#13;
&#13;
Nader ME, Gidley PW. Challenges of Hearing Rehabilitation after Radiation and Chemotherapy. J Neurol Surg B Skull Base 2019; 80: 214-224.&#13;
&#13;
Schultz C, Goffi-Gomez MV, Pecora Liberman PH, Pellizzon AC, Carvalho AL. Hearing loss and complaint in patients with head and neck cancer treated with radiotherapy. Arch Otolaryngol Head Neck Surg 2010; 136: 1065-1069.&#13;
&#13;
Singh IP, Slevin NJ. Late audiovestibular consequences of radical radiotherapy to the parotid. Clin Oncol (R Coll Radiol) 1991; 3: 217-219.&#13;
&#13;
Sood S, McGurk M, Vaz F. Management of Salivary Gland Tumours: United Kingdom National Multidisciplinary Guidelines. J Laryngol Otol 2016; 130: S142-S149.&#13;
&#13;
Stramandinoli-Zanicotti RT, Sassi LM, Schussel JL, Torres MF, Funchal M, Smaniotto GH, Dissenha JL, Carvalho AL. Effect of fractionated radiotherapy on the parotid gland: an experimental study in Brazilian minipigs. Int Arch Otorhinolaryngol 2013 Apr;17(2):163-167.&#13;
&#13;
Theunissen EA, Zuur CL, Yurda ML, van der Baan S, Kornman AF, de Boer JP, Balm AJ, Rasch CR, Dreschler WA. Cochlea sparing effects of intensity modulated radiation therapy in head and neck cancers patients: a long-term follow-up study. J Otolaryngol Head Neck Surg 2014; 43: 30.&#13;
&#13;
Thielker J, Grosheva M, Ihrler S, Wittig A, Guntinas-Lichius O. Contemporary Management of Benign and Malignant Parotid Tumors. Front Surg 2018; 5: 39.&#13;
&#13;
van der Putten L, de Bree R, Plukker JT, Langendijk JA, Smits C, Burlage FR, Leemans CR. Permanent unilateral hearing loss after radiotherapy for parotid gland tumors. Head Neck 2006; 28: 902-908.&#13;
&#13;
Wells GA, Shea B, Oand;#39;Connell D, Peterson J, Welch V, Losos M, Tugwell P. (2009) The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses [Online]. Ontario: Ottawa Hospital Research Institute. Available: http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp 25 March 2014].</References>
      </References>
    </Journal>
  </Article>
</ArticleSet>